Raised S.B. No. 1202
Session Year 2023


To (1) require that certain prescription drugs purchased in the state not exceed upper payment limits set by Medicare pursuant to the federal Inflation Reduction Act, (2) establish a Prescription Drug Payment Evaluation Committee to recommend upper payment limits on not less than eight drugs based on such limits in other states or countries, and (3) require the Office of Health Strategy to monitor and make public the costliest prescription drugs.

Introduced by:
Human Services Committee

 New today  2-4 days old  5 days & older
   Text of Bill
 Raised Bill  [doc]

Co-sponsors for Amendment LCO:

Bill History

 Date Action Taken
 3/21/2023(HS)Joint Favorable Change of Reference Insurance and Real Estate
 3/10/2023Public Hearing 03/16
 3/9/2023Referred to Joint Committee on Human Services

NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.